FDI in pharmaceuticals in 2021: The state of play
The Covid-19 pandemic caused overall greenfield foreign direct investment (FDI) project numbers to decline by 17.5% in 2020. However, as…
All articles by Sofia Karadima
Sofia Karadima
Sofia Karadima is a senior editor and researcher at Investment Monitor, focusing on financial and business services, and ESG investing. She previously covered institutional investment across private markets for financial news and research provider Acuris. She has reported on private equity, venture capital, private debt and infrastructure, among other topics. Sofia is currently based in London, after living in Chile, Denmark, Spain and Greece.
-
-
Foreign investments amplify the nucleic acid therapeutics field
The Covid-19 pandemic caused overall greenfield foreign direct investment (FDI) project numbers to decline by 17.5% in 2020. However, as the world…
-
FDI drivers in 2022: ESG
Embracing environmental, social and governance (ESG) criteria is rising in importance as a driver of foreign direct investment (FDI), with…
-
FDI in pharmaceuticals: The state of play
The Covid-19 pandemic caused overall foreign direct investment (FDI) project numbers to decline by 17.4% in 2020, when compared with…
-
Holistic thinking is prescribed for investors on World Health Day 2022
'Our planet, our health' is the theme for the 2022 World Health Day, underlining that environmental factors impact heavily on…
-
An ethical dilemma: Should companies still sell essential products in Russia?
Several multinational companies have opted to walk away from Russia following its invasion of Ukraine. However, some companies in the…